NADH: A Crucial Coenzyme in Energy Metabolism (G4539)

Target Name: ND4L

NCBI ID: G4539

ND4L

NADH: A Crucial Coenzyme in Energy Metabolism

NADH (nicotinamide adenine dinucleotide) is a crucial coenzyme found in all living cells that plays a vital role in energy metabolism. NAD+ is a dinucleotide, consisting of two nucleotides joined together, and it has a central carbon atom that is bonded to a nitrogen atom. NADH is often referred to as the 鈥渞ed nucleotide鈥? due to its role in the production of energy in the cell.

Mitochondria are organelles found in the cells that are responsible for generating energy through a process called cellular respiration. Mitochondria are also the site of the production of NADH, which is a crucial coenzyme in this process. NADH is produced from tryptophan, a protein that is synthesized in the cytoplasm of the mitochondria.

ND4L (nicotinamide dinucleotide 4-likelihood) is a protein that is encoded by theND4 gene in the mitochondria. It is a key enzyme in the production of NADH, and it has been shown to play a crucial role in the regulation of cellular respiration. In this article, we will discuss the research on ND4L and its potential as a drug target or biomarker.

The Importance of NADH

NADH is a crucial coenzyme that is involved in the production of energy in the cell. It is a dinucleotide, consisting of two nucleotides joined together, and it has a central carbon atom that is bonded to a nitrogen atom. NAD+ is a red nucleotide due to its role in the production of energy in the cell.

NADH is produced from tryptophan, a protein that is synthesized in the cytoplasm of the mitochondria. The production of NADH is regulated by various factors, including the levels of oxygen, the availability of electrons, and the concentration of other nutrients.

ND4L plays a crucial role in the production of NADH in the mitochondria. It is an enzyme that is responsible for the conversion of tryptophan to NADH. ND4L is a key enzyme in the production of NADH, and it has been shown to play a crucial role in the regulation of cellular respiration.

The Potential of ND4L as a Drug Target

ND4L has been shown to be a potential drug target in the treatment of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. The reason for its potential as a drug target is its involvement in the production of NADH, which is a crucial coenzyme in energy metabolism.

Studies have shown that ND4L can inhibit the activity of various enzymes involved in the production of NADH, which can lead to an increase in the production of NADH. This increase in NADH can lead to a decrease in the production of reactive oxygen species (ROS), which can have a beneficial effect on the cell.

ND4L has also been shown to interact with various signaling pathways, including the PI3K/AKT signaling pathway, which is involved in the regulation of cellular respiration. This interaction between ND4L and the PI3K/AKT signaling pathway suggests that ND4L may have potential as a drug target for the treatment of various diseases.

The Potential of ND4L as a Biomarker

ND4L has also been shown to be a potential biomarker for the diagnosis and monitoring of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. The reason for its potential as a biomarker is its involvement in the production of NADH, which is a crucial coenzyme in energy metabolism.

Studies have shown that ND4L can be used as a biomarker for the diagnosis of cancer by analyzing the levels of NADH in the urine or plasma. This analysis can indicate the presence of cancer cells in the body. Additionally, ND4L has

Protein Name: Mitochondrially Encoded NADH 4L Dehydrogenase

Functions: Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor

The "ND4L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ND4L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets